Please see below for a list of search results.
These guides set out your basic rights when dealing with an establishment regulated by the HTA.
The HTA has been asked to provide information on how many child bone marrow/blood cases were approved and rejected in the years 2014-15 and 2015-16.
Schedule 1 of the Human Tissue Act 2004 (the Act) sets out ‘performance assessment’ as a ‘scheduled purpose’.
An HTA licence is required if the human cellular material (‘relevant material’) to be stored for performance assessment has been removed from the deceased.
A decade ago it first became possible for individuals in the UK to donate a kidney to someone they did not know, and had never met - this form of living donation is known as non-directed altruistic donation.
The Human Tissue Act 2004 covers England, Wales and Northern Ireland. It established the HTA to regulate activities concerning the removal, storage, use and disposal of human tissue.
This policy sets out the legal requirements of the HT Act with regard to consent for post-mortem examination, tissue retention and storage of tissue from the deceased.
This position statement outlines guidance provided on consent for post-mortem examination and tissue retention.
The HTA licenses a number of activities relating to human tissue. We are also responsible for carrying out inspections to ensure licence conditions are being met. These activities are laid out in the Human Tissue Act and associated Regulations.
The activities licensed by the HTA are:
The Human Tissue Act covers primarily England, Wales and Northern Ireland; only section 45 and schedule 4 of the Human Tissue Act include Scotland. There is separate legislation in Scotland – the Human Tissue (Scotland) Act 2006 – and the HTA performs certain tasks on behalf of the Scottish...